MANKINDBSEMANKIND PHARMA LIMITEDHighNegative
Announced Mon, 28 Sept, 2026 · 15:49 IST

BSV subsidiary auditor resigns due to voluntary liquidation

Auditor Resigned MidtermManagement Changes View source PDFExplain this filing

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹2435.60
prior close
₹2436.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.5+1.3+1.0+2.4+2.8+4.1+1.8+2.6+2.6—————
Up moveDown movePending
AI summary

S.R. Batliboi and Co. LLP resigned as Statutory Auditors of Bharat Serums and Vaccines Limited (BSV), Mankind Pharma's wholly owned subsidiary, effective September 28, 2026. BSV shareholders resolved on September 7, 2026 to voluntarily liquidate the company under the Insolvency and Bankruptcy Code. IBC voluntary liquidation rules bar a liquidator from engaging any professional who served as auditor in the prior five years, forcing the resignation. BSV's audit for FY ending March 31, 2026 was completed on May 12, 2026; the FY27 audit had not begun.

Likely market impact

BSV, a Mankind subsidiary, is being voluntarily wound down. No impact on Mankind's own statutory audit; reflects routine subsidiary liquidation process.